Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fennec Pharmaceuticals Inc. (FENC)
USD10.68
-0.48 (-4.30%)
US NASDAQ Healthcare Biotechnology
Address
68 TW Alexander Drive 27709
Research Triangle Park, NC, US
Research Triangle Park, NC, US
CEO
Jeffrey S. Hackman
Website
fennecpharma.com
IPO
2017-09-15
CIK 1211583 ISIN CA31447P1009
Also trades on
NASDAQ Capital Market · FENC (USD)
Toronto Stock Exchange · FRX.TO (CAD)
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
News Sentiment (7d)
Based on only 1 article — low confidence
- Is the Options Market Predicting a Spike in Adherex Technologies Stock? Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD10.68
-0.48 (-4.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
269.5K
Beta
1.08
Float Shares
13.66M
Free Float %
47.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +36.48% | +33.14% | +47.84% | +9.74% | +17.56% | +20.00% | +45.97% | +20.94% | +46.43% | -23.00% | -23.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
10.68
Low
18.00
+68.5%
Consensus
18.00
+68.5%
Median
18.00
+68.5%
High
18.00
+68.5%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
16.00
+49.8%
|
| All Time | 8 |
16.38
+53.4%
|
Quality scores
Altman Z-Score
3.11
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-6.1% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-2,150.0% Q1'26: +123.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-55.4%
-
EBIT margin Biotechnology: +0.0%-16.9%
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+4.7% Q1'26: +28.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 50.56M (-100.0%)
|
1.47M
est: 882.2K (+67.1%)
|
21.25M
est: 48.89M (-56.5%)
|
47.54M
est: 43.03M (+10.5%)
|
44.64M
est: 45.60M (-2.1%)
|
67.24M
59.97M – 75.01M
+47.4% YoY
|
101.13M
99.82M – 102.88M
+50.4% YoY
|
133.03M
131.45M – 134.61M
+31.5% YoY
|
188.69M
169.82M – 208.69M
+41.8% YoY
|
205.79M
185.22M – 227.60M
+9.1% YoY
|
| EBITDA |
-17.07M
est: -47.21M (+63.8%)
|
-21.69M
est: -84.8K (-25,467.3%)
|
-12.36M
est: -6.18M (-100.1%)
|
4.80M
est: -5.44M (+188.2%)
|
-7.45M
est: -5.76M (-29.3%)
|
-8.50M
-9.48M – -7.58M
-47.4% YoY
|
-12.78M
-13.00M – -12.62M
-50.4% YoY
|
-16.81M
-17.01M – -16.61M
-31.5% YoY
|
-23.85M
-26.37M – -21.46M
-41.8% YoY
|
-26.01M
-28.77M – -23.41M
-9.1% YoY
|
| EBIT |
-17.07M
est: -20.89M (+18.3%)
|
-21.69M
est: -266.6K (-8,035.4%)
|
-12.65M
est: -6.48M (-95.4%)
|
4.00M
est: -5.70M (+170.2%)
|
-7.56M
est: -6.04M (-25.1%)
|
-8.91M
-9.94M – -7.94M
-47.4% YoY
|
-13.39M
-13.63M – -13.22M
-50.4% YoY
|
-17.62M
-17.83M – -17.41M
-31.5% YoY
|
-24.99M
-27.64M – -22.49M
-41.8% YoY
|
-27.26M
-30.15M – -24.53M
-9.1% YoY
|
| Net Income |
-17.19M
est: -47.38M (+63.7%)
|
-22.77M
est: -24.62M (+7.5%)
|
-16.05M
est: 2.74M (-686.7%)
|
-436.0K
est: -2.07M (+79.0%)
|
-9.74M
est: -3.58M (-172.0%)
|
2.07M
658.2K – 6.25M
+157.7% YoY
|
22.26M
17.30M – 27.23M
+978.0% YoY
|
48.42M
27.19M – 50.91M
+117.5% YoY
|
72.59M
63.15M – 82.59M
+49.9% YoY
|
76.68M
66.72M – 87.25M
+5.6% YoY
|
| SGA |
12.13M
est: 33.26M (-63.5%)
|
19.69M
est: 16.40M (+20.1%)
|
32.71M
est: 174.36M (-81.2%)
|
41.48M
est: 153.46M (-73.0%)
|
46.91M
est: 162.63M (-71.2%)
|
239.79M
213.88M – 267.52M
+47.4% YoY
|
360.68M
356.00M – 366.92M
+50.4% YoY
|
474.44M
468.80M – 480.07M
+31.5% YoY
|
672.94M
605.68M – 744.29M
+41.8% YoY
|
733.93M
660.57M – 811.74M
+9.1% YoY
|
| EPS |
-0.67
est: 0.26 (-362.0%)
|
-0.95
est: -0.90 (-5.3%)
|
-0.60
est: 0.10 (-691.5%)
|
-0.02
est: -0.07 (+77.9%)
|
-0.36
est: -0.13 (-177.7%)
|
0.13
0.02 – 0.22
+197.7% YoY
|
0.84
0.61 – 0.95
+566.0% YoY
|
1.44
0.95 – 1.78
+71.0% YoY
|
2.54
2.21 – 2.89
+76.1% YoY
|
2.68
2.33 – 3.05
+5.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-16 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
10.26M
OE per share TTM
3.39
Owner's Yield
3.23%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
589,131,856.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
30
Total invested
21.14M
Insider transactions (90d)
8
Beneficial owners (>5%)
33
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 20-0975900 | 62.26M | 42.40% | — | — | — | — | OO | : | 2007-03-02 | ↗ |
| 2 | John S. Clark II | 62.26M | 42.40% | — | — | — | — | IN | : | 2007-03-02 | ↗ |
| 3 | Robert W. Butts | 62.26M | 42.40% | — | — | — | — | IN | : | 2007-03-02 | ↗ |
| 4 | Southpoint Offshore Fund, Ltd. | 62.26M | 42.40% | — | — | — | — | PN | : | 2007-03-02 | ↗ |
| 5 | William P. Peters | 10.93M | 5.98% | — | — | — | — | IN | States | 2005-07-13 | ↗ |
| 6 | Advisors LLC | 4.08M | 15.80% | — | 4.08M | — | 4.08M | OO | Delaware | 2021-02-12 | ↗ |
| 7 | Advisors LP | 4.08M | 15.80% | — | 4.08M | — | 4.08M | PN | Delaware | 2021-02-12 | ↗ |
| 8 | Fund, LP | 4.08M | 15.80% | — | 4.08M | — | 4.08M | PN | Delaware | 2021-02-12 | ↗ |
| 9 | II | 4.08M | 15.80% | — | 4.08M | — | 4.08M | IN | Delaware | 2021-02-12 | ↗ |
| 10 | LLC | 4.08M | 15.80% | — | 4.08M | — | 4.08M | OO | Delaware | 2021-02-12 | ↗ |
| 11 | LP | 4.08M | 15.80% | — | 4.08M | — | 4.08M | PN | Delaware | 2021-02-12 | ↗ |
| 12 | 2 | 4.00M | 21.90% | — | — | — | — | PN | Cayman Islands | 2018-02-14 | ↗ |
| 13 | Enrico Cavazza | 3.23M | 17.70% | — | 3.23M | — | 3.23M | IN | Italy | 2017-12-19 | ↗ |
| 14 | Essetifin S.p.A. | 3.23M | 17.70% | — | 3.23M | — | 3.23M | CO | Italy | 2017-12-19 | ↗ |
| 15 | Francesca Cavazza | 3.23M | 17.70% | — | 3.23M | — | 3.23M | IN | Italy | 2017-12-19 | ↗ |
| 16 | Martina Cavazza Preta | 3.23M | 17.70% | — | 3.23M | — | 3.23M | IN | Italy | 2017-12-19 | ↗ |
| 17 | Paolo Cavazza | 3.23M | 17.70% | — | 3.23M | — | 3.23M | IN | Italy | 2017-12-19 | ↗ |
| 18 | Silvia Cavazza | 3.23M | 17.70% | — | 3.23M | — | 3.23M | IN | Italy | 2017-12-19 | ↗ |
| 19 | GlaxoSmithKline plc | 2.79M | 7.50% | 2.79M | — | 2.79M | — | CO | England and Wales | 2006-02-10 | ↗ |
| 20 | LAWRENCE KAM | 2.47M | 9.50% | — | — | 62.5K | 2.41M | IN | DELAWARE | 2022-02-14 | ↗ |
| 21 | THE SONIC FUND II, L.P. | 2.41M | 9.30% | — | — | — | 2.41M | PN | DELAWARE | 2022-02-14 | ↗ |
| 22 | DG Capital Management, LLC | 1.42M | 5.20% | — | 1.42M | — | 1.42M | IA | Delaware, USA | 2024-06-27 | ↗ |
| 23 | DG Value Partners II Master Fund, LP | 1.42M | 5.20% | — | 1.42M | — | 1.42M | PN | Delaware, USA | 2024-06-27 | ↗ |
| 24 | Dov Gertzulin | 1.42M | 5.20% | — | 1.42M | — | 1.42M | HC, IN | Delaware, USA | 2024-06-27 | ↗ |
| 25 | 2. | 1.38M | 5.20% | — | 1.38M | — | 1.38M | HC, IN | Delaware | 2024-02-14 | ↗ |
| 26 | Avoro Capital Advisors LLC | 1.20M | 4.60% | 1.20M | — | 1.20M | — | IA, OO | Delaware | 2022-02-11 | ↗ |
| 27 | Behzad Aghazadeh | 1.20M | 4.60% | 1.20M | — | 1.20M | — | IN | United States | 2022-02-11 | ↗ |
| 28 | venBio Select Advisor LLC | 1.11M | 6.10% | 1.11M | — | 1.11M | — | IA, OO | Delaware | 2018-02-12 | ↗ |
| 29 | 683 Capital Management, LLC | 971.4K | 4.90% | — | 971.4K | — | 971.4K | IA | Delaware | 2019-02-14 | ↗ |
| 30 | 683 Capital Partners, LP | 971.4K | 4.90% | — | 971.4K | — | 971.4K | PN | Delaware | 2019-02-14 | ↗ |
| 31 | Ari Zweiman | 971.4K | 4.90% | — | 971.4K | — | 971.4K | IN | Delaware | 2019-02-14 | ↗ |
| 32 | 1 | 9.00 | 11.00% | — | 925.0K | — | 925.0K | EP, IN | Delaware | 2018-06-22 | ↗ |
| 33 | Opaleye Management Inc. | 9.00 | 11.00% | — | 925.0K | — | 925.0K | EP, IN | Delaware | 2018-06-22 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
30
-65 vs prev Q
New positions
6
Closed positions
71
Increased
17
Reduced
6
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | POTOMAC CAPITAL MANAGEMENT, INC. | 95.1K +95.1K (+100.0%) | 732.27M +732.3M (+100.0%) | 0.34% +0.341 pp | 0.59% +0.588 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 2 | SOUTHPOINT CAPITAL ADVISORS LP | 2.74M -1.3M (-32.7%) | 21.13M -17.0M (-44.6%) | 9.84% -4.897 pp | 0.49% -0.510 pp | USD11.04 -30.3% | 34 qtrs — |
| 3 | ROSALIND ADVISORS, INC. | 2.61M +536.7K (+25.8%) | 20.12M +684.8K (+3.5%) | 9.37% +1.864 pp | 7.07% +0.428 pp | USD6.79 +13.4% | 5 qtrs — |
| 4 | SOLAS CAPITAL MANAGEMENT, LLC | 2.56M +372.8K (+17.0%) | 19.72M -761.2K (-3.7%) | 9.18% +1.273 pp | 11.19% -1.312 pp | USD6.05 +27.3% | 27 qtrs — |
| 5 | AIGH CAPITAL MANAGEMENT LLC | 1.58M +900.0K (+132.1%) | 12.18M +5.8M (+90.9%) | 5.67% +3.207 pp | 2.95% +1.150 pp | USD7.61 +1.2% | 4 qtrs — |
| 6 | BLACKROCK, INC. | 1.23M +22.5K (+1.9%) | 9.50M -1.8M (-16.2%) | 4.43% +0.045 pp | 0.00% +0.000 pp | USD5.07 +51.9% | 6 qtrs — |
| 7 | VANGUARD GROUP INC | 1.07M +111.9K (+11.7%) | 8.22M -725.0K (-8.1%) | 3.83% +0.373 pp | 0.00% +0.000 pp | USD10.53 -26.9% | 11 qtrs — |
| 8 | AWM INVESTMENT COMPANY, INC. | 711.9K +711.9K (+100.0%) | 5.48M +5.5M (+100.0%) | 2.55% +2.553 pp | 0.53% +0.529 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 9 | STATE STREET CORP | 352.8K +11.6K (+3.4%) | 2.72M -477.3K (-14.9%) | 1.26% +0.032 pp | 0.00% +0.000 pp | USD8.76 -12.1% | 11 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 297.1K -3.7K (-1.2%) | 2.29M -527.6K (-18.7%) | 1.07% -0.022 pp | 0.00% +0.000 pp | USD8.09 -4.8% | 23 qtrs — |
| 11 | MORGAN STANLEY | 242.5K +10.1K (+4.3%) | 1.87M -308.2K (-14.2%) | 0.87% +0.029 pp | 0.00% +0.000 pp | USD6.82 +12.9% | 33 qtrs — |
| 12 | APIS CAPITAL ADVISORS, LLC | 204.0K +204.0K (+100.0%) | 1.57M +1.6M (+100.0%) | 0.73% +0.732 pp | 0.27% +0.274 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 13 | CITADEL ADVISORS LLC | 199.7K +92.3K (+85.8%) | 1.54M +531.9K (+52.9%) | 0.72% +0.328 pp | 0.00% +0.000 pp | USD8.35 -7.8% | 3 qtrs — |
| 14 | GENDELL JEFFREY L | 139.6K +— (+0.0%) | 1.07M -231.7K (-17.7%) | 0.50% -0.004 pp | 0.02% -0.005 pp | USD9.17 -16.0% | 13 qtrs — |
| 15 | MARSHALL WACE, LLP | 127.7K +127.7K (+100.0%) | 983.2K +983.2K (+100.0%) | 0.46% +0.458 pp | 0.00% +0.001 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 16 | LION POINT CAPITAL, LP | 112.4K -10.6K (-8.6%) | 865.7K -285.5K (-24.8%) | 0.40% -0.042 pp | 4.48% -2.060 pp | USD8.59 -10.4% | 11 qtrs — |
| 17 | NORTHERN TRUST CORP | 112.1K -18.5K (-14.1%) | 863.1K -358.9K (-29.4%) | 0.40% -0.070 pp | 0.00% +0.000 pp | USD7.94 -3.0% | 11 qtrs — |
| 18 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83.0K +52.3K (+170.4%) | 639.1K +351.8K (+122.4%) | 0.30% +0.187 pp | 0.01% +0.007 pp | USD8.00 -3.8% | 3 qtrs — |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 57.2K +— (+0.0%) | 440.8K -95.0K (-17.7%) | 0.21% -0.002 pp | 0.00% +0.000 pp | USD8.01 -3.9% | 11 qtrs — |
| 20 | TREXQUANT INVESTMENT LP | 51.4K +51.4K (+100.0%) | 395.6K +395.6K (+100.0%) | 0.18% +0.184 pp | 0.00% +0.004 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 21 | STATE OF WISCONSIN INVESTMENT BOARD | 51.0K +18.9K (+58.9%) | 392.7K +92.2K (+30.7%) | 0.18% +0.067 pp | 0.00% +0.000 pp | USD7.21 +6.8% | 7 qtrs — |
| 22 | HARTFORD FINANCIAL MANAGEMENT INC. | 50.6K +— (+0.0%) | 390.0K -84.1K (-17.7%) | 0.18% -0.002 pp | 0.10% -0.024 pp | USD7.11 +8.3% | 34 qtrs — |
| 23 | STONEPINE CAPITAL MANAGEMENT, LLC | 50.0K +50.0K (+100.0%) | 385.0K +385.0K (+100.0%) | 0.18% +0.179 pp | 0.28% +0.281 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 24 | BANK OF NEW YORK MELLON CORP | 49.2K -3.1K (-5.9%) | 379.0K -110.3K (-22.5%) | 0.18% -0.013 pp | 0.00% +0.000 pp | USD8.05 -4.3% | 11 qtrs — |
| 25 | QUBE RESEARCH & TECHNOLOGIES LTD | 44.7K +44.7K (+100.0%) | 344.1K +344.1K (+100.0%) | 0.16% +0.160 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 26 | HILLSDALE INVESTMENT MANAGEMENT INC. | 44.0K +44.0K (+100.0%) | 338.8K +338.8K (+100.0%) | 0.16% +0.158 pp | 0.01% +0.009 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 27 | GOLDMAN SACHS GROUP INC | 43.6K +17.1K (+64.5%) | 335.6K +87.7K (+35.4%) | 0.16% +0.061 pp | 0.00% +0.000 pp | USD7.79 -1.2% | 25 qtrs — |
| 28 | BARCLAYS PLC | 36.6K +5.3K (+16.9%) | 281.8K +125.2K (+80.0%) | 0.13% +0.018 pp | 0.00% +0.000 pp | USD7.31 +5.3% | 13 qtrs — |
| 29 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 32.5K +5.4K (+20.0%) | 249.9K -3.3K (-1.3%) | 0.12% +0.019 pp | 0.00% +0.000 pp | USD8.20 -6.1% | 3 qtrs — |
| 30 | RHUMBLINE ADVISERS | 29.0K -4.5K (-13.4%) | 223.6K -90.2K (-28.7%) | 0.10% -0.017 pp | 0.00% 0.000 pp | USD7.72 -0.3% | 11 qtrs — |
| 31 | 1492 CAPITAL MANAGEMENT LLC | 28.1K +28.1K (+100.0%) | 216.3K +216.3K (+100.0%) | 0.10% +0.101 pp | 0.08% +0.083 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 32 | ACADIAN ASSET MANAGEMENT LLC | 27.1K +16.4K (+152.7%) | 207.0K +107.0K (+107.0%) | 0.10% +0.058 pp | 0.00% +0.000 pp | USD8.36 -7.9% | 2 qtrs — |
| 33 | XTX TOPCO LTD | 26.8K +5.5K (+26.1%) | 206.3K +7.4K (+3.7%) | 0.10% +0.019 pp | 0.01% -0.005 pp | USD9.02 -14.6% | 2 qtrs — |
| 34 | WELLS FARGO & COMPANY/MN | 26.2K +9.1K (+53.7%) | 201.4K +42.2K (+26.5%) | 0.09% +0.032 pp | 0.00% +0.000 pp | USD7.88 -2.3% | 12 qtrs — |
| 35 | NUVEEN, LLC | 26.0K +— (+0.0%) | 200.2K -43.2K (-17.7%) | 0.09% -0.001 pp | 0.00% +0.000 pp | USD6.09 +26.4% | 4 qtrs — |
| 36 | JONES FINANCIAL COMPANIES LLLP | 25.0K +15.6K (+165.4%) | 192.1K +107.2K (+126.1%) | 0.09% +0.056 pp | 0.00% +0.000 pp | USD6.95 +10.8% | 7 qtrs — |
| 37 | MILLENNIUM MANAGEMENT LLC | 24.4K +12.3K (+102.1%) | 187.9K +74.9K (+66.2%) | 0.09% +0.044 pp | 0.00% +0.000 pp | USD8.00 -3.8% | 3 qtrs — |
| 38 | JANE STREET GROUP, LLC | 24.0K -48.6K (-66.9%) | 185.1K -494.7K (-72.8%) | 0.09% -0.176 pp | 0.00% 0.000 pp | USD8.18 -5.9% | 8 qtrs — |
| 39 | BANK OF AMERICA CORP /DE/ | 22.5K +9.1K (+67.6%) | 173.5K +47.7K (+37.9%) | 0.08% +0.032 pp | 0.00% +0.000 pp | USD7.53 +2.3% | 24 qtrs — |
| 40 | POINT72 ASSET MANAGEMENT, L.P. | 21.3K +21.3K (+100.0%) | 164.0K +164.0K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 41 | RENAISSANCE TECHNOLOGIES LLC | 20.0K +9.4K (+88.7%) | 154.0K +54.8K (+55.2%) | 0.07% +0.033 pp | 0.00% +0.000 pp | USD8.58 -10.3% | 2 qtrs — |
| 42 | DEUTSCHE BANK AG\ | 17.4K +17.4K (+100.0%) | 133.7K +133.7K (+100.0%) | 0.06% +0.062 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 3 qtrs — |
| 43 | AQR CAPITAL MANAGEMENT LLC | 15.1K +127.0 (+0.8%) | 116.6K -23.9K (-17.0%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD6.75 +14.1% | 4 qtrs — |
| 44 | HIGHTOWER ADVISORS, LLC | 15.0K +— (+0.0%) | 115.5K -24.9K (-17.7%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD8.30 -7.2% | 3 qtrs — |
| 45 | QUADRATURE CAPITAL LTD | 14.8K -560.0 (-3.7%) | 113.7K -29.9K (-20.8%) | 0.05% -0.003 pp | 0.00% -0.001 pp | USD9.36 -17.7% | 2 qtrs — |
| 46 | INVESCO LTD. | 14.3K +2.2K (+18.1%) | 110.3K -3.2K (-2.8%) | 0.05% +0.008 pp | 0.00% +0.000 pp | USD8.26 -6.8% | 3 qtrs — |
| 47 | LAZARD ASSET MANAGEMENT LLC | 13.1K +13.1K (+100.0%) | 101.0K +101.0K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 48 | SQUAREPOINT OPS LLC | 13.1K +13.1K (+100.0%) | 100.9K +100.9K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 49 | METLIFE INVESTMENT MANAGEMENT, LLC | 13.0K +3.4K (+35.7%) | 100.2K +10.5K (+11.6%) | 0.05% +0.012 pp | 0.00% +0.000 pp | USD6.99 +10.2% | 11 qtrs — |
| 50 | TWO SIGMA ADVISERS, LP | 13.0K +13.0K (+100.0%) | 100.1K +100.1K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 51 | PRICE T ROWE ASSOCIATES INC /MD/ | 12.5K +— (+0.0%) | 97.0K -21.0K (-17.8%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD8.41 -8.4% | 3 qtrs — |
| 52 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 10.9K -20.0 (-0.2%) | 83.7K -18.2K (-17.9%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD5.99 +28.5% | 7 qtrs — |
| 53 | INTECH INVESTMENT MANAGEMENT LLC | 10.5K -932.0 (-8.2%) | 80.5K -26.1K (-24.5%) | 0.04% -0.004 pp | 0.00% 0.000 pp | USD6.26 +23.0% | 5 qtrs — |
| 54 | ALLIANCEBERNSTEIN L.P. | 10.3K +— (+0.0%) | 79.4K -17.1K (-17.7%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD9.36 -17.7% | 2 qtrs — |
| 55 | JPMORGAN CHASE & CO | 9.8K -55.0 (-0.6%) | 75.2K -16.7K (-18.2%) | 0.04% -0.001 pp | 0.00% +0.000 pp | USD8.56 -10.0% | 16 qtrs — |
| 56 | NEW YORK STATE COMMON RETIREMENT FUND | 9.8K +— (+0.0%) | 75.1K -16.2K (-17.7%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD8.81 -12.6% | 11 qtrs — |
| 57 | LEGAL & GENERAL GROUP PLC | 8.1K +— (+0.0%) | 62.8K -13.1K (-17.3%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD8.29 -7.1% | 11 qtrs — |
| 58 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.3K +— (+0.0%) | 48.1K -10.4K (-17.7%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD6.32 +21.8% | 5 qtrs — |
| 59 | STRS OHIO | 5.2K +— (+0.0%) | 40.0K -8.6K (-17.7%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD9.36 -17.7% | 2 qtrs — |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 5.1K +543.0 (+12.0%) | 38.9K -3.3K (-7.8%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD8.61 -10.6% | 31 qtrs — |
| 61 | UBS GROUP AG | 5.0K -8.7K (-63.6%) | 38.5K -89.9K (-70.0%) | 0.02% -0.032 pp | 0.00% +0.000 pp | USD7.23 +6.5% | 34 qtrs — |
| 62 | RUSSELL INVESTMENTS GROUP, LTD. | 2.9K -750.0 (-20.4%) | 22.5K -11.9K (-34.5%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD9.08 -15.2% | 10 qtrs — |
| 63 | FEDERATED HERMES, INC. | 2.9K +— (+0.0%) | 22.5K -4.8K (-17.7%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD9.07 -15.1% | 3 qtrs — |
| 64 | ROYAL BANK OF CANADA | 2.5K +1.4K (+122.1%) | 19.0K +9.0K (+90.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD7.12 +8.1% | 23 qtrs — |
| 65 | FMR LLC | 2.4K -301.0 (-11.0%) | 18.7K -6.8K (-26.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD8.80 -12.5% | 16 qtrs — |
| 66 | CIBC PRIVATE WEALTH GROUP, LLC | 1.6K +— (+0.0%) | 12.1K -2.6K (-17.7%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD10.84 -29.0% | 8 qtrs — |
| 67 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 1.6K +1.6K (+100.0%) | 12.0K +12.0K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 68 | AMERITAS INVESTMENT PARTNERS, INC. | 1.5K +— (+0.0%) | 11.5K -2.5K (-17.7%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD8.83 -12.8% | 11 qtrs — |
| 69 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.4K -258.0 (-15.2%) | 11.1K -4.8K (-30.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD8.83 -12.8% | 11 qtrs — |
| 70 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.4K -240.0 (-14.8%) | 10.7K -4.5K (-29.9%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD7.83 -1.7% | 17 qtrs — |
| 71 | STERLING CAPITAL MANAGEMENT LLC | 1.0K -168.0 (-14.0%) | 7.9K -3.3K (-29.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD8.32 -7.5% | 6 qtrs — |
| 72 | AMALGAMATED BANK | 736.00 -85.0 (-10.4%) | 6.0K -2.0K (-25.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD8.13 -5.3% | 11 qtrs — |
| 73 | CWM, LLC | 750.00 -61.0 (-7.5%) | 6.0K -2.0K (-25.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD6.85 +12.4% | 6 qtrs — |
| 74 | PNC FINANCIAL SERVICES GROUP, INC. | 637.00 -331.0 (-34.2%) | 4.9K -4.2K (-45.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.39 +20.5% | 9 qtrs — |
| 75 | CITIGROUP INC | 530.00 -281.0 (-34.6%) | 4.1K -3.5K (-45.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.75 +14.1% | 13 qtrs — |
| 76 | PINNACLE WEALTH PLANNING SERVICES, INC. | 507.00 +507.0 (+100.0%) | 3.9K +3.9K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 77 | MASSMUTUAL TRUST CO FSB/ADV | 357.00 +— (+0.0%) | 2.7K -593.0 (-17.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.24 +23.4% | 6 qtrs — |
| 78 | STATE OF WYOMING | 309.00 +7.0 (+2.3%) | 2.4K -448.0 (-15.8%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD8.29 -7.1% | 12 qtrs — |
| 79 | UBS ASSET MANAGEMENT AMERICAS INC | 303.00 +303.0 (+100.0%) | 2.3K +2.3K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 80 | FARTHER FINANCE ADVISORS, LLC | 274.00 +— (+0.0%) | 2.1K -455.0 (-17.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.36 -17.7% | 2 qtrs — |
| 81 | PRIVATE WEALTH MANAGEMENT GROUP, LLC | 247.00 +— (+0.0%) | 1.9K -410.0 (-17.7%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD6.22 +23.8% | 5 qtrs — |
| 82 | QUAKER WEALTH MANAGEMENT, LLC | 160.00 +160.0 (+100.0%) | 1.2K +1.2K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 83 | EVERSOURCE WEALTH ADVISORS, LLC | 135.00 +— (+0.0%) | 1.0K -225.0 (-17.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.31 +22.0% | 5 qtrs — |
| 84 | GAMMA INVESTING LLC | 113.00 +— (+0.0%) | 870.00 -188.0 (-17.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.13 +25.6% | 4 qtrs — |
| 85 | SMARTLEAF ASSET MANAGEMENT LLC | 110.00 +— (+0.0%) | 854.00 -145.0 (-14.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.32 +21.8% | 5 qtrs — |
| 86 | NATIONAL BANK OF CANADA /FI/ | 97.00 -89.0 (-47.8%) | 747.00 -1.1K (-59.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD8.95 -14.0% | 4 qtrs — |
| 87 | HUGHES FINANCIAL SERVICES, LLC | 97.00 -11.0 (-10.2%) | 747.00 -82.0 (-9.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.08 +26.6% | 4 qtrs — |
| 88 | CORNERSTONE PLANNING GROUP LLC | 88.00 +— (+0.0%) | 656.00 -77.0 (-10.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.00 +54.0% | 8 qtrs — |
| 89 | ADVISOR GROUP HOLDINGS, INC. | 75.00 -19.0 (-20.2%) | 577.00 -277.0 (-32.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD6.97 +10.5% | 20 qtrs — |
| 90 | OPTIMA CAPITAL LLC | 63.00 +63.0 (+100.0%) | 485.00 +485.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.70 +0.0% | 1 qtrs NEW |
| 91 | NISA INVESTMENT ADVISORS, LLC | 46.00 +— (+0.0%) | 354.00 -77.0 (-17.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.59 +37.7% | 7 qtrs — |
| 92 | TD WATERHOUSE CANADA INC. | 29.00 +— (+0.0%) | 223.00 -8.0 (-3.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.66 -11.1% | 3 qtrs — |
| 93 | SUNBELT SECURITIES, INC. | 7.00 +— (+0.0%) | 54.00 -12.0 (-18.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.29 -17.1% | 2 qtrs — |
| 94 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 6.00 +— (+0.0%) | 46.00 -8.0 (-14.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.33 -17.5% | 2 qtrs — |
| 95 | TRUE WEALTH DESIGN, LLC | 1.00 +1.0 (+100.0%) | 8.00 +8.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.00 +10.0% | 1 qtrs NEW |
| 96 | SIMPLEX TRADING, LLC | — -21.3K (-100.0%) | — -199.0K (-100.0%) | 0.00% -0.077 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 97 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -17.0K (-100.0%) | — -159.3K (-100.0%) | 0.00% -0.062 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 98 | TANG CAPITAL MANAGEMENT LLC | — -334.6K (-100.0%) | — -3.1M (-100.0%) | 0.00% -1.210 pp | 0.00% -0.121 pp | USD— | 3 qtrs SOLD |
| 99 | SBI SECURITIES CO., LTD. | — -1.0 (-100.0%) | — -9.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 100 | FRANKLIN RESOURCES INC | — -17.0K (-100.0%) | — -158.9K (-100.0%) | 0.00% -0.061 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 19 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Russell 2000 Value ETF VTWV | 0.01% | 169.0K | 0.06% |
| 2 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.01% | 52.6K | 0.36% |
| 3 | Global X - Russell 2000 ETF RSSL | 0.01% | 142.5K | 0.08% |
| 4 | Vanguard Russell 2000 ETF VTWO | 0.01% | 1.45M | 0.06% |
| 5 | ProShares - Ultra Russell2000 UWM | 0.00% | 12.0K | 1.07% |
| 6 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 68.3K | 0.06% |
| 7 | ProShares - UltraPro Russell2000 URTY | 0.00% | 11.5K | 1.08% |
| 8 | ProShares - Hedge Replication ETF HDG | 0.00% | 293.73 | 0.95% |
| 9 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 17.2K | 0.03% |
| 10 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 47.1K | 0.17% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.50
Neutral
Ratio by volume
0.68
Neutral
Buys
9
Sells
6
Shares acquired
51.7K
Shares disposed
75.6K
Cash buys
—
Cash sales
3.00
Net activity
-23,942
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | RALLIS CHRIS A | Director | M-Exempt | D | Stock Option | 14,344 | 2.44 | 35.0K | 186,189 | D | ↗ |
| 2026-05-01 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 15,598 | 2.45 | 38.2K | 1,571,792 | D | ↗ |
| 2026-04-30 | Sayad Pierre Sargis | Officer | M-Exempt | A | Common Shares | 168 | 0.00 | — | 20,847 | D | ↗ |
| 2026-04-30 | Raykov Rosty | Director | M-Exempt | A | Common shares | 2,778 | 0.00 | — | 116,634 | D | ↗ |
| 2026-04-30 | Hackman Jeffrey S. | Director / Officer | M-Exempt | A | Common Shares | 1,159 | 0.00 | — | 61,666 | D | ↗ |
| 2026-04-30 | Evans Terry L | Officer | M-Exempt | A | Common Shares | 168 | 0.00 | — | 20,847 | D | ↗ |
| 2026-04-30 | Cioffi Christiana Marie | Officer | M-Exempt | A | Common shares | 155 | 0.00 | — | 24,020 | D | ↗ |
| 2026-04-30 | Andrade Robert | Officer | M-Exempt | A | Common shares | 1,703 | 0.00 | — | 287,566 | D | ↗ |
| 2026-04-01 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 15,598 | 2.45 | 38.2K | 1,587,390 | D | ↗ |
| 2026-03-31 | Sayad Pierre Sargis | Officer | M-Exempt | A | Common Shares | 18,456 | 0.00 | — | 18,456 | D | ↗ |
| 2026-03-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 109,204 | D | ↗ |
| 2026-03-31 | Hackman Jeffrey S. | Director / Officer | M-Exempt | A | Common Shares | 16,695 | 0.00 | — | 45,405 | D | ↗ |
| 2026-03-31 | Evans Terry L | Officer | M-Exempt | A | Common Shares | 18,456 | 0.00 | — | 18,456 | D | ↗ |
| 2026-03-31 | Cioffi Christiana Marie | Officer | M-Exempt | A | Common shares | 17,106 | 0.00 | — | 21,806 | D | ↗ |
| 2026-03-31 | Andrade Robert | Officer | M-Exempt | A | Common shares | 14,724 | 0.00 | — | 271,380 | D | ↗ |
| 2026-03-28 | Sayad Pierre Sargis | Officer | M-Exempt | A | Common shares | 2,052 | 0.00 | — | 20,679 | D | ↗ |
| 2026-03-28 | Hackman Jeffrey S. | Director / Officer | M-Exempt | A | Common Shares | 13,943 | 0.00 | — | 60,507 | D | ↗ |
| 2026-03-28 | Evans Terry L | Officer | M-Exempt | A | Common shares | 2,052 | 0.00 | — | 20,679 | D | ↗ |
| 2026-03-28 | Cioffi Christiana Marie | Officer | M-Exempt | A | Common shares | 1,901 | 0.00 | — | 23,865 | D | ↗ |
| 2026-03-28 | Andrade Robert | Officer | M-Exempt | A | Common shares | 12,270 | 0.00 | — | 285,863 | D | ↗ |
| 2026-03-26 | Cioffi Christiana Marie | Officer | M-Exempt | D | Stock Options | 4,700 | 4.23 | 19.9K | 145,300 | D | ↗ |
| 2026-03-26 | Andrade Robert | Officer | M-Exempt | A | Common shares | 13,072 | 5.10 | 66.7K | 256,656 | D | ↗ |
| 2026-03-02 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 15,598 | 2.45 | 38.2K | 1,587,390 | D | ↗ |
| 2026-02-28 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 109,204 | D | ↗ |
| 2026-02-28 | Andrade Robert | Officer | A-Award | A | Common shares | 1,191 | 0.00 | — | 243,584 | D | ↗ |
| 2026-02-18 | Hackman Jeffrey S. | Director / Officer | M-Exempt | A | Common Shares | 13,710 | 0.00 | — | 28,710 | D | ↗ |
| 2026-02-18 | Andrade Robert | Officer | M-Exempt | A | Common shares | 2,450 | 4.08 | 10.0K | 215,108 | D | ↗ |
| 2026-02-02 | Raykov Rosty | Director | M-Exempt | A | Common shares | 15,598 | 2.45 | 38.2K | 108,826 | D | ↗ |
| 2026-01-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 93,228 | D | ↗ |
| 2026-01-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,558 | 0.00 | — | 212,658 | D | ↗ |
| 2026-01-23 | Andrade Robert | Officer | M-Exempt | D | Stock Options | 10,000 | 2.45 | 24.5K | 816,567 | D | ↗ |
| 2026-01-15 | Andrade Robert | Officer | M-Exempt | D | Stock Options | 10,000 | 2.45 | 24.5K | 826,567 | D | ↗ |
| 2026-01-07 | Andrade Robert | Officer | M-Exempt | D | Stock Options | 14,184 | 2.45 | 34.8K | 836,567 | D | ↗ |
| 2026-01-02 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 15,598 | 2.45 | 38.2K | 1,618,586 | D | ↗ |
| 2025-12-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 82,734 | D | ↗ |
| 2025-12-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,382 | 0.00 | — | 176,916 | D | ↗ |
| 2025-12-24 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 1,000,000 | 7.50 | 7.50M | 2,744,741 | I | ↗ |
| 2025-12-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 7.54 | 75.4K | 77,526 | D | ↗ |
| 2025-12-01 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 87,526 | D | ↗ |
| 2025-12-01 | Andrade Robert | Officer | A-Award | A | Common shares | 2,430 | 0.00 | — | 175,534 | D | ↗ |
| 2025-11-18 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 19,341 | 8.79 | 170.0K | 3,744,741 | I | ↗ |
| 2025-11-17 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 85,918 | 8.79 | 755.2K | 3,764,082 | I | ↗ |
| 2025-11-14 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 160,100 | 8.00 | 1.28M | 3,850,000 | I | ↗ |
| 2025-11-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 8.10 | 81.0K | 82,318 | D | ↗ |
| 2025-10-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 92,318 | D | ↗ |
| 2025-10-31 | Andrade Robert | Officer | A-Award | A | Common shares | 2,430 | 0.00 | — | 173,104 | D | ↗ |
| 2025-10-10 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 4,062 | 1.23 | 5.0K | 58,854 | D | ↗ |
| 2025-10-09 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 20,609 | 9.35 | 192.6K | 4,010,100 | I | ↗ |
| 2025-10-08 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 19,605 | 9.47 | 185.7K | 4,030,709 | I | ↗ |
| 2025-10-08 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 4,609 | 2.45 | 11.3K | 1,634,184 | D | ↗ |
| 2025-10-07 | Southpoint Capital Advisors LP | 10% Owner | S-Sale | D | Common Stock | 26,900 | 9.59 | 257.9K | 4,050,314 | I | ↗ |
| 2025-10-06 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 9.78 | 97.8K | 82,501 | D | ↗ |
| 2025-09-30 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 92,501 | D | ↗ |
| 2025-09-30 | Andrade Robert | Officer | A-Award | A | Common shares | 2,430 | 0.00 | — | 170,674 | D | ↗ |
| 2025-09-05 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 36,207 | 2.45 | 88.7K | 1,638,793 | D | ↗ |
| 2025-09-04 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 8.92 | 89.2K | 51,086 | D | ↗ |
| 2025-08-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 61,086 | D | ↗ |
| 2025-08-31 | Andrade Robert | Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 168,244 | D | ↗ |
| 2025-08-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 8.09 | 80.9K | 55,878 | D | ↗ |
| 2025-08-05 | Hackman Jeffrey S. | Director / Officer | — | D | Stock Options | 400,000 | 5.58 | 2.23M | 0 | — | ↗ |
| 2025-07-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 65,878 | D | ↗ |
| 2025-07-31 | Andrade Robert | Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 165,813 | D | ↗ |
| 2025-07-07 | RALLIS CHRIS A | Director | M-Exempt | D | Common Shares | 2,127 | 2.35 | 5.0K | 178,406 | D | ↗ |
| 2025-07-03 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 8.61 | 86.1K | 60,670 | D | ↗ |
| 2025-06-30 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 70,670 | D | ↗ |
| 2025-06-30 | Andrade Robert | Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 163,382 | D | ↗ |
| 2025-06-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 7.78 | 77.8K | 65,462 | D | ↗ |
| 2025-06-03 | RALLIS CHRIS A | Director | A-Award | A | Stock Option | 20,000 | 7.88 | 157.6K | 200,533 | D | ↗ |
| 2025-06-03 | Islam Khalid | Director | A-Award | A | Stock Option | 25,000 | 7.88 | 197.0K | 225,000 | D | ↗ |
| 2025-06-03 | Cook Jodi A | Director | A-Award | A | Stock Options | 20,000 | 7.88 | 157.6K | 140,000 | D | ↗ |
| 2025-06-03 | Brughera Marco Maria | Director | A-Award | A | Stock Option | 20,000 | 7.88 | 157.6K | 215,545 | D | ↗ |
| 2025-05-31 | Raykov Rosty | Director | A-Award | A | Common shares | 5,208 | 0.00 | — | 75,462 | D | ↗ |
| 2025-05-31 | Andrade Robert | Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 160,951 | D | ↗ |
| 2025-05-22 | Andrade Robert | Officer | M-Exempt | D | Stock Options | 8,220 | 5.10 | 41.9K | 850,751 | D | ↗ |
| 2025-05-19 | Hackman Jeffrey S. | Director / Officer | P-Purchase | A | Common Shares | 13,965 | 6.99 | 97.6K | 15,000 | D | ↗ |
| 2025-05-16 | Raykov Rosty | Director | S-Sale | D | Common shares | 16,667 | 6.78 | 113.0K | 70,254 | D | ↗ |
| 2025-05-16 | Hackman Jeffrey S. | Director / Officer | P-Purchase | A | Common Shares | 1,035 | 6.75 | 7.0K | 1,035 | D | ↗ |
| 2025-05-16 | Andrade Robert | Officer | A-Award | A | Common shares | 16,667 | 0.00 | — | 150,300 | D | ↗ |
| 2025-05-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 6.31 | 63.1K | 53,587 | D | ↗ |
| 2025-04-30 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 63,587 | D | ↗ |
| 2025-04-30 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 133,633 | D | ↗ |
| 2025-04-04 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 5.25 | 52.5K | 61,156 | D | ↗ |
| 2025-03-31 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 71,156 | D | ↗ |
| 2025-03-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 132,591 | D | ↗ |
| 2025-03-28 | Sayad Pierre Sargis | Officer | A-Award | A | Restricted Share Unit | 10,000 | 0.00 | — | 160,000 | D | ↗ |
| 2025-03-28 | Hackman Jeffrey S. | Director / Officer | A-Award | A | Stock Options | 50,000 | 6.50 | 325.0K | 450,000 | D | ↗ |
| 2025-03-28 | Evans Terry L | Officer | A-Award | A | Restricted Share Unit | 10,000 | 0.00 | — | 10,000 | D | ↗ |
| 2025-03-28 | Cioffi Christiana Marie | Officer | A-Award | A | Restricted Share Unit | 10,000 | 0.00 | — | 10,000 | D | ↗ |
| 2025-03-28 | Andrade Robert | Officer | A-Award | A | Stock Options | 50,000 | 6.50 | 325.0K | 877,722 | D | ↗ |
| 2025-03-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 6.79 | 67.9K | 68,725 | D | ↗ |
| 2025-02-28 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 78,725 | D | ↗ |
| 2025-02-28 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 131,549 | D | ↗ |
| 2025-02-14 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 1,992 | 2.51 | 5.0K | 54,206 | D | ↗ |
| 2025-02-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 10,000 | 6.66 | 66.6K | 76,294 | D | ↗ |
| 2025-01-31 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 86,294 | D | ↗ |
| 2025-01-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 130,507 | D | ↗ |
| 2025-01-06 | Raykov Rosty | Director | S-Sale | D | Common shares | 2,431 | 6.08 | 14.8K | 91,432 | D | ↗ |
| 2024-12-31 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 93,863 | D | ↗ |
| 2024-12-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 129,465 | D | ↗ |
| 2024-12-20 | Raykov Rosty | Director | M-Exempt | D | Stock Options | 25,000 | 2.69 | 67.3K | 1,675,000 | D | ↗ |
| 2024-12-05 | Raykov Rosty | Director | S-Sale | D | Common shares | 796 | 6.04 | 4.8K | 66,432 | D | ↗ |
| 2024-12-03 | Raykov Rosty | Director | S-Sale | D | Common shares | 1,635 | 6.13 | 10.0K | 67,228 | D | ↗ |
| 2024-12-02 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 68,863 | D | ↗ |
| 2024-12-02 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 10,000 | 2.69 | 26.9K | 58,623 | D | ↗ |
| 2024-12-02 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 128,423 | D | ↗ |
| 2024-11-18 | Andrade Robert | Officer | M-Exempt | D | Stock Options | 15,816 | 2.45 | 38.7K | 689,184 | D | ↗ |
| 2024-11-13 | Sayad Pierre Sargis | Officer | A-Award | A | Stock Options | 150,000 | 4.23 | 634.5K | 150,000 | D | ↗ |
| 2024-11-13 | Evans Terry L | Officer | A-Award | A | Stock Options | 150,000 | 4.23 | 634.5K | 150,000 | D | ↗ |
| 2024-11-13 | Cioffi Christiana Marie | Officer | A-Award | A | Stock Options | 150,000 | 4.23 | 634.5K | 150,000 | D | ↗ |
| 2024-11-04 | Raykov Rosty | Director | S-Sale | D | Common shares | 2,431 | 4.31 | 10.5K | 66,432 | D | ↗ |
| 2024-10-31 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 68,863 | D | ↗ |
| 2024-10-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 111,565 | D | ↗ |
| 2024-10-28 | Sayad Pierre Sargis | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-28 | Evans Terry L | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-28 | Cioffi Christiana Marie | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-08 | RALLIS CHRIS A | Director | M-Exempt | D | Common Shares | 1,960 | 2.55 | 5.0K | 194,698 | D | ↗ |
| 2024-10-01 | Raykov Rosty | Director | S-Sale | D | Common shares | 2,431 | 4.94 | 12.0K | 66,432 | D | ↗ |
| 2024-09-30 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 68,863 | D | ↗ |
| 2024-09-30 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 110,523 | D | ↗ |
| 2024-09-04 | Raykov Rosty | Director | S-Sale | D | Common shares | 2,431 | 5.52 | 13.4K | 66,432 | — | ↗ |
| 2024-08-31 | Raykov Rosty | Director | A-Award | A | Common shares | 2,431 | 0.00 | — | 68,863 | — | ↗ |
| 2024-08-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 109,481 | — | ↗ |
| 2024-08-23 | Raykov Rosty | Director | G-Gift | D | Common shares | 26,001 | 0.00 | — | 66,432 | — | ↗ |
| 2024-08-15 | RALLIS CHRIS A | Director | A-Award | A | Stock Option | 20,000 | 5.58 | 111.6K | 196,658 | — | ↗ |
| 2024-08-15 | Islam Khalid | Director | A-Award | A | Stock Option | 25,000 | 5.58 | 139.5K | 200,000 | — | ↗ |
| 2024-08-15 | Hackman Jeffrey S. | Director / Officer | A-Award | A | Stock Options | 400,000 | 5.58 | 2.23M | 400,000 | — | ↗ |
| 2024-08-15 | Cook Jodi A | Director | A-Award | A | Stock Options | 20,000 | 5.58 | 111.6K | 120,000 | — | ↗ |
| 2024-08-15 | Brughera Marco Maria | Director | A-Award | A | Stock Option | 20,000 | 5.58 | 111.6K | 195,545 | — | ↗ |
| 2024-08-01 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 2,431 | 6.26 | 15.2K | 187,471 | — | ↗ |
| 2024-07-31 | Raykov Rosty | Director / Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 189,902 | — | ↗ |
| 2024-07-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 108,439 | — | ↗ |
| 2024-07-05 | RALLIS CHRIS A | Director | M-Exempt | D | Common Shares | 1,792 | 2.79 | 5.0K | 179,802 | — | ↗ |
| 2024-07-02 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 2,431 | 6.13 | 14.9K | 187,471 | — | ↗ |
| 2024-07-01 | Raykov Rosty | Director / Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 189,902 | — | ↗ |
| 2024-07-01 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 107,397 | — | ↗ |
| 2024-06-03 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 2,431 | 6.76 | 16.4K | 187,471 | — | ↗ |
| 2024-05-31 | Raykov Rosty | Director / Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 189,902 | — | ↗ |
| 2024-05-31 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 106,355 | — | ↗ |
| 2024-05-16 | Raykov Rosty | Director / Officer | A-Award | A | Restricted Share Unit | 100,000 | 0.00 | — | 1,855,902 | — | ↗ |
| 2024-05-16 | Haigh Adrian | Officer | A-Award | A | Restricted Shste Unit | 25,000 | 0.00 | — | 435,246 | — | ↗ |
| 2024-05-16 | Andrade Robert | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 7.12 | 712.0K | 728,958 | — | ↗ |
| 2024-05-01 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 2,431 | 9.11 | 22.2K | 187,471 | — | ↗ |
| 2024-04-30 | Raykov Rosty | Director / Officer | A-Award | A | Common shares | 2,431 | 0.00 | — | 189,902 | — | ↗ |
| 2024-04-30 | Andrade Robert | Officer | A-Award | A | Common shares | 1,042 | 0.00 | — | 105,313 | — | ↗ |
| 2024-04-22 | Haigh Adrian | Officer | S-Sale | D | Common Shares | 22,223 | 9.32 | 207.0K | 0 | — | ↗ |
| 2024-04-19 | Haigh Adrian | Officer | M-Exempt | D | Option | 22,222 | 2.31 | 51.3K | 382,469 | — | ↗ |
| 2024-04-18 | Haigh Adrian | Officer | S-Sale | D | Common Shares | 22,222 | 9.62 | 213.8K | 0 | — | ↗ |
| 2024-04-17 | Haigh Adrian | Officer | M-Exempt | A | Common Shares | 22,222 | 2.31 | 51.3K | 22,222 | — | ↗ |
| 2024-04-16 | Haigh Adrian | Officer | S-Sale | D | Common Shares | 22,222 | 10.28 | 228.4K | 0 | — | ↗ |
| 2024-04-15 | RALLIS CHRIS A | Director | S-Sale | D | Common Shares | 800 | 10.45 | 8.4K | 44,449 | — | ↗ |
| 2024-04-15 | Haigh Adrian | Officer | M-Exempt | A | Common Shares | 22,222 | 2.31 | 51.3K | 22,222 | — | ↗ |
| 2024-04-05 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 44,300 | 10.75 | 476.3K | 187,471 | — | ↗ |
| 2024-04-04 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 14,583 | 10.89 | 158.9K | 261,471 | — | ↗ |
| 2024-04-03 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 26,000 | 10.78 | 280.3K | 276,054 | — | ↗ |
| 2024-04-01 | Raykov Rosty | Director / Officer | P-Purchase | A | Common shares | 29,167 | 0.00 | — | 316,638 | — | ↗ |
| 2024-04-01 | Andrade Robert | Officer | P-Purchase | A | Common shares | 12,500 | 0.00 | — | 104,271 | — | ↗ |
| 2024-03-26 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 4,329 | 2.31 | 10.0K | 45,249 | — | ↗ |
| 2024-03-26 | Andrade Robert | Officer | S-Sale | D | Common shares | 13,975 | 10.90 | 152.3K | 91,771 | — | ↗ |
| 2024-03-25 | Andrade Robert | Officer | S-Sale | D | Common shares | 13,975 | 11.00 | 153.7K | 105,746 | — | ↗ |
| 2024-01-05 | Andrade Robert | Officer | S-Sale | D | Common shares | 15,000 | 10.41 | 156.2K | 119,721 | — | ↗ |
| 2024-01-04 | Andrade Robert | Officer | S-Sale | D | Common shares | 15,000 | 10.64 | 159.6K | 134,721 | — | ↗ |
| 2023-12-28 | Raykov Rosty | Director / Officer | M-Exempt | A | Common shares | 8,540 | 1.59 | 13.6K | 291,127 | — | ↗ |
| 2023-12-26 | RALLIS CHRIS A | Director | M-Exempt | D | Common Shares | 3,144 | 1.59 | 5.0K | 184,168 | — | ↗ |
| 2023-11-20 | RALLIS CHRIS A | Director | S-Sale | D | Common Shares | 269 | 8.25 | 2.2K | 43,034 | — | ↗ |
| 2023-11-16 | Islam Khalid | Director | M-Exempt | D | Common Shares | 133,333 | 2.31 | 308.0K | 255,492 | — | ↗ |
| 2023-11-08 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 7,995 | 7.90 | 63.2K | 282,587 | — | ↗ |
| 2023-11-03 | Raykov Rosty | Director / Officer | M-Exempt | D | Option Contract | 74,793 | 1.59 | 118.9K | 1,596,040 | — | ↗ |
| 2023-08-18 | RALLIS CHRIS A | Director | S-Sale | D | Common Shares | 673 | 7.85 | 5.3K | 43,303 | — | ↗ |
| 2023-08-07 | Haigh Adrian | Officer | A-Award | A | Stock Option | 200,000 | 8.03 | 1.61M | 493,579 | — | ↗ |
| 2023-07-24 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 16,666 | 0.72 | 12.0K | 50,772 | — | ↗ |
| 2023-07-06 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 5,280 | 0.96 | 5.1K | 34,106 | — | ↗ |
| 2023-06-30 | Andrade Robert | Officer | M-Exempt | A | Common shares | 25,000 | 2.45 | 61.3K | 149,721 | — | ↗ |
| 2023-06-29 | Andrade Robert | Officer | S-Sale | D | Common shares | 7,500 | 8.97 | 67.3K | 132,221 | — | ↗ |
| 2023-06-28 | Andrade Robert | Officer | S-Sale | D | Common shares | 10,000 | 8.99 | 89.9K | 139,721 | — | ↗ |
| 2023-06-12 | RALLIS CHRIS A | Director | A-Award | A | Stock Option | 20,000 | 8.78 | 175.6K | 209,186 | — | ↗ |
| 2023-06-12 | Islam Khalid | Director | A-Award | A | Stock Option | 25,000 | 8.78 | 219.5K | 388,825 | — | ↗ |
| 2023-06-12 | Haigh Adrian | Director | A-Award | A | Stock Option | 20,000 | 8.78 | 175.6K | 294 | — | ↗ |
| 2023-06-12 | Cook Jodi A | Director | A-Award | A | Stock Options | 20,000 | 8.78 | 175.6K | 100,000 | — | ↗ |
| 2023-06-12 | Brughera Marco Maria | Director | A-Award | A | Stock Option | 20,000 | 8.78 | 175.6K | 175,545 | — | ↗ |
| 2023-05-19 | RALLIS CHRIS A | Director | S-Sale | D | Common Shares | 925 | 7.36 | 6.8K | 31,033 | — | ↗ |
| 2023-04-17 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 1,700 | 2.94 | 5.0K | 33,777 | — | ↗ |
| 2023-03-31 | Raykov Rosty | Director / Officer | A-Award | A | Restricted Share Unit | 87,500 | 0.00 | — | 1,670,833 | — | ↗ |
| 2023-03-31 | Andrade Robert | Officer | A-Award | A | Restricted Share Unit (right to receive value of a share) | 37,500 | 0.00 | — | 667,500 | — | ↗ |
| 2023-03-03 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 4,166 | 2.40 | 10.0K | 34,184 | — | ↗ |
| 2022-12-30 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 8,400 | 9.61 | 80.8K | 217,838 | — | ↗ |
| 2022-12-30 | Andrade Robert | Director / Officer | S-Sale | D | Common shares | 5,500 | 9.61 | 52.9K | 149,721 | — | ↗ |
| 2022-12-29 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 5,000 | 9.65 | 48.3K | 227,838 | — | ↗ |
| 2022-12-29 | Andrade Robert | Director / Officer | S-Sale | D | Common shares | 5,500 | 9.57 | 52.7K | 155,221 | — | ↗ |
| 2022-12-28 | Raykov Rosty | Director / Officer | S-Sale | D | Common shares | 13,740 | 9.59 | 131.8K | 232,838 | — | ↗ |
| 2022-12-28 | Andrade Robert | Director / Officer | S-Sale | D | Common shares | 11,000 | 9.61 | 105.8K | 160,721 | — | ↗ |
| 2022-11-17 | RALLIS CHRIS A | Director | S-Sale | D | Common Shares | 333 | 7.99 | 2.7K | 30,018 | — | ↗ |
| 2022-10-20 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 4,762 | 1.05 | 5.0K | 32,419 | — | ↗ |
| 2022-09-21 | Andrade Robert | Officer | A-Award | A | Common shares | 37,500 | 0.00 | — | 190,773 | — | ↗ |
| 2022-09-09 | Raykov Rosty | Director / Officer | M-Exempt | A | Commons Shares | 16,666 | 0.72 | 12.0K | 263,244 | — | ↗ |
| 2022-08-22 | Raykov Rosty | Officer | M-Exempt | A | Common Shares | 50,000 | 1.05 | 52.5K | 246,578 | — | ↗ |
| 2022-07-18 | RALLIS CHRIS A | Director | M-Exempt | A | Common Shares | 11,111 | 0.45 | 5.0K | 32,036 | — | ↗ |
| 2022-06-14 | RALLIS CHRIS A | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-14 | Islam Khalid | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-14 | Haigh Adrian | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.59 | 111.8K | 20,000 | — | ↗ |
| 2022-06-14 | Cook Jodi A | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.59 | 111.8K | 20,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-236.1K
Shares Outstanding
28.58M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Robert Andrade, CFO | 482.1K | 70.6K | 1.12M | 202.9K | — | — | 1.87M | 70.49% | ↗ |
| 2 | 2025 | Jeffrey Hackman, CEO | 586.3K | 45.8K | 887.1K | 202.9K | — | — | 1.72M | 63.29% | ↗ |
| 3 | 2025 | Pierre S. Sayad, CMO | 464.1K | — | 311.0K | — | — | — | 775.1K | 40.12% | ↗ |
| 4 | 2024 | Rostislav Raykov, former CEO | 411.6K | 611.3K | 712.0K | 894.8K | — | 608.7K | 3.24M | 49.62% | ↗ |
| 5 | 2024 | Robert Andrade, CFO | 463.6K | 494.4K | 356.0K | 447.4K | — | — | 1.76M | 45.61% | ↗ |
| 6 | 2024 | Jeffrey Hackman, CEO | 225.0K | — | — | 1.39M | — | — | 1.61M | 86.04% | ↗ |
| 7 | 2024 | Jeff Hackman, CEO | 225.0K | — | — | 1.39M | — | — | 1.61M | 86.04% | ↗ |
| 8 | 2024 | Pierre S. Sayad, CMO | 81.3K | — | — | 402.3K | — | — | 483.5K | 83.20% | ↗ |
| 9 | 2024 | Pierre Sayad, CMO | 81.3K | — | — | 402.3K | — | — | 483.5K | 83.20% | ↗ |
| 10 | 2023 | Rostislav Raykov, former CEO | 607.1K | 278.0K | 728.0K | 927.9K | — | — | 2.54M | 65.17% | ↗ |
| 11 | 2023 | Rostislav Raykov, CEO | 607.1K | 278.0K | 728.0K | 927.9K | — | — | 2.54M | 65.17% | ↗ |
| 12 | 2023 | Adrian Haigh, COO | 183.9K | 167.8K | — | 1.00M | — | — | 1.35M | 74.04% | ↗ |
| 13 | 2023 | Robert Andrade, CFO | 439.8K | 161.1K | 312.0K | 397.7K | — | — | 1.31M | 54.15% | ↗ |
| 14 | 2022 | Rostislav Raykov, CEO | 503.4K | 110.7K | — | — | — | — | 614.2K | 0.00% | ↗ |
| 15 | 2022 | Robert Andrade, CFO | 364.7K | 64.2K | — | — | — | — | 428.9K | 0.00% | ↗ |
| 16 | 2022 | Shubh Goel, CCO | 8.6K | — | — | — | — | — | 8.6K | 0.00% | ↗ |
| 17 | 2021 | Rostislav Raykov, CEO | 468.5K | — | — | 2.95M | — | — | 3.42M | 86.30% | ↗ |
| 18 | 2021 | Shubh Goel, CCO | 376.5K | — | 153.0K | 1.01M | — | — | 1.54M | 75.49% | ↗ |
| 19 | 2021 | Robert Andrade, CFO | 339.4K | — | 153.0K | 1.01M | — | — | 1.50M | 77.35% | ↗ |
| 20 | 2020 | Rostislav Raykov, CEO | 430.0K | — | — | 1.69M | — | — | 1.48M | 114.74% | ↗ |
| 21 | 2020 | Robert Andrade, CFO | 311.8K | — | — | 847.1K | — | — | 1.16M | 73.10% | ↗ |
| 22 | 2020 | Shubh Goel, CCO | 360.0K | — | — | 169.4K | — | — | 529.4K | 32.00% | ↗ |
| 23 | 2019 | Rostislav Raykov, CEO | 488.7K | 157.5K | — | 830.9K | — | — | 1.48M | 56.28% | ↗ |
| 24 | 2019 | Shubh Goel, CCO | 98.0K | 115.0K | — | 816.5K | — | — | 1.03M | 79.31% | ↗ |
| 25 | 2019 | Robert Andrade, CFO | 325.2K | 100.0K | — | 438.6K | — | — | 863.8K | 50.77% | ↗ |
| 26 | 2018 | Rostislav Raykov, CEO | 350.0K | 160.0K | — | 562.3K | — | — | 1.07M | 52.44% | ↗ |
| 27 | 2018 | Robert Andrade, CFO | 250.0K | 110.0K | — | 309.1K | — | — | 669.1K | 46.20% | ↗ |
| 28 | 2017 | Rostislav Raykov, CEO | 262.5K | — | — | 187.6K | — | — | 450.1K | 41.68% | ↗ |
| 29 | 2017 | Robert Andrade, CFO | 195.0K | — | — | 93.8K | — | — | 288.8K | 32.48% | ↗ |
| 30 | 2016 | Robert Andrade, CFO | 177.5K | — | — | 268.9K | — | — | 446.4K | 60.24% | ↗ |
| 31 | 2016 | Rostislav Raykov, CEO | 215.0K | — | — | 156.9K | — | — | 371.9K | 42.19% | ↗ |
| 32 | 2015 | Rostislav Raykov, CEO | 180.0K | — | — | — | — | — | 180.0K | 0.00% | ↗ |
| 33 | 2015 | Robert Andrade, CFO | 110.8K | — | — | — | — | — | 110.8K | 0.00% | ↗ |
| 34 | 2014 | Rostislav Raykov, Chief Executive Officer | 178.5K | 40.0K | — | 199.8K | — | — | 418.2K | 47.76% | ↗ |
| 35 | 2014 | Rostislav Raykov, CEO | 178.5K | 40.0K | — | 199.8K | — | — | 418.2K | 47.76% | ↗ |
| 36 | 2014 | Krysia Lynes, Interim Chief Financial Officer | 139.7K | 5.0K | — | 15.9K | — | — | 160.6K | 9.90% | ↗ |
| 37 | 2014 | Krysia Lynes, Former Interim CFO | 139.7K | 5.0K | — | 15.9K | — | — | 160.6K | 9.90% | ↗ |
| 38 | 2013 | Rostislav Raykov, CEO | 140.0K | — | — | 11.7K | — | — | 151.7K | 7.69% | ↗ |
| 39 | 2013 | Rostislav Raykov, Chief Executive Officer | 140.0K | — | — | 11.7K | — | — | 151.7K | 7.69% | ↗ |
| 40 | 2013 | Robert Andrade, Former Chief Financial Officer | 109.5K | — | — | — | — | — | 109.5K | 0.00% | ↗ |
| 41 | 2013 | Robert Andrade, CFO | 109.5K | — | — | — | — | — | 109.5K | 0.00% | ↗ |
| 42 | 2013 | Dr. Thomas Spector Chief Scientific Officer | 71.5K | — | — | — | — | 30.0K | 101.5K | 0.00% | ↗ |
| 43 | 2013 | Krysia Lynes, Interim Chief Financial Officer | 26.5K | — | — | 11.7K | — | — | 38.1K | 30.59% | ↗ |
| 44 | 2013 | Krysia Lynes, Former Interim CFO | 26.5K | — | — | 11.7K | — | — | 30.1K | 38.71% | ↗ |
| 45 | 2012 | Dr. Thomas Spector Chief Scientific Officer | 150.0K | — | — | 48.0K | — | — | 198.0K | 24.25% | ↗ |
| 46 | 2012 | Robert Andrade, Chief Financial Officer | 140.0K | — | — | 48.0K | — | — | 188.0K | 25.54% | ↗ |
| 47 | 2012 | Rostislav Raykov, Chief Executive Officer | 140.0K | — | — | 48.0K | — | — | 188.0K | 25.54% | ↗ |
| 48 | 2012 | Robert Andrade, Former Chief Financial Officer | 140.0K | — | — | 48.0K | — | — | 188.0K | 25.54% | ↗ |
| 49 | 2012 | Krysia Lynes, Interim Chief Financial Officer | 17.1K | — | — | 7.4K | — | — | 24.5K | 30.07% | ↗ |
| 50 | 2011 | Dr. Thomas Spector Chief Scientific Officer | 150.0K | — | — | 32.2K | — | — | 182.2K | 17.68% | ↗ |
| 51 | 2011 | Robert Andrade, Chief Financial Officer | 140.0K | — | — | 32.2K | — | — | 172.2K | 18.71% | ↗ |
| 52 | 2011 | Rostislav Raykov, Chief Executive Officer | 140.0K | — | — | 32.2K | — | — | 172.2K | 18.71% | ↗ |
| 53 | 2010 | Rostislav Raykov, Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 54 | 2010 | Robert Andrade, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 55 | 2010 | Dr. William P. Peters Former Chief Executive | — | — | — | — | — | — | — | — | ↗ |
| 56 | 2010 | James A. Klein, Jr. Previously Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 57 | 2010 | Dr. Robin J. Norris Previously President and | — | — | — | — | — | — | — | — | ↗ |
| 58 | 2010 | D. Scott Murray, Previously Senior Vice | — | — | — | — | — | — | — | — | ↗ |
| 59 | 2010 | Dr. Thomas Spector Chief Scientific Officer | — | — | — | — | — | — | — | — | ↗ |
| 60 | 2009 | Dr. William P. Peters Former Chief Executive | 298.6K | 115.0K | — | — | — | — | 413.6K | 0.00% | ↗ |
| 61 | 2009 | Dr. William P. Peters Former Chief Executive | 298.6K | 115.0K | — | — | — | — | 413.6K | 0.00% | ↗ |
| 62 | 2009 | Dr. Robin J. Norris President and Chief Operating Officer | 208.0K | 35.0K | — | 9.0K | — | — | 252.0K | 3.57% | ↗ |
| 63 | 2009 | Dr. Robin J. Norris Previously President and | 208.0K | 35.0K | — | 9.0K | — | — | 252.0K | 3.57% | ↗ |
| 64 | 2009 | James A. Klein, Jr. | 180.9K | 35.0K | — | — | — | — | 215.9K | 0.00% | ↗ |
| 65 | 2009 | James A. Klein, Jr. Previously Chief Financial | 180.9K | 35.0K | — | — | — | — | 215.9K | 0.00% | ↗ |
| 66 | 2009 | D. Scott Murray, Previously Senior Vice | 123.8K | 65.0K | — | — | — | — | 188.8K | 0.00% | ↗ |
| 67 | 2009 | Dr. Thomas Spector Chief Scientific Officer | 45.8K | — | — | — | — | — | 45.8K | 0.00% | ↗ |
| 68 | 2009 | Robert Andrade, Chief | 11.6K | — | — | — | — | — | 11.6K | 0.00% | ↗ |
| 69 | 2009 | Rostislav Raykov, Chief Executive Officer | 11.6K | — | — | — | — | — | 11.6K | 0.00% | ↗ |
| 70 | 2009 | Robert Andrade, Chief Financial Officer | 11.6K | — | — | — | — | — | 11.6K | 0.00% | ↗ |
| 71 | 2009 | Rostislav Raykov, Chief | 11.6K | — | — | — | — | — | 11.6K | 0.00% | ↗ |
| 72 | 2008 | Dr. William P. Peters Chief Executive Officer and Chairman | 495.0K | — | — | 1.09M | 97.4K | 2.9K | 1.69M | 64.31% | ↗ |
| 73 | 2008 | Dr. Robin J. Norris President and Chief Operating Officer | 255.0K | — | — | 282.1K | 30.0K | 3.6K | 570.8K | 49.43% | ↗ |
| 74 | 2008 | D. Scott Murray, Senior Vice President, General Counsel and Secretary | 233.0K | — | — | 274.7K | 41.4K | 1.5K | 550.7K | 49.89% | ↗ |
| 75 | 2008 | James A. Klein, Jr. Chief Financial Officer | 233.0K | — | — | 267.6K | 27.0K | 1.8K | 529.4K | 50.55% | ↗ |
| 76 | 2007 | Dr. William P. Peters Chief Executive Officer and Chairman | 486.9K | — | — | 946.2K | 150.0K | 3.1K | 1.59M | 59.65% | ↗ |
| 77 | 2007 | D. Scott Murray, Senior Vice President, General Counsel and Secretary | 230.0K | 25.0K | — | 300.2K | 50.0K | 1.2K | 606.4K | 49.50% | ↗ |
| 78 | 2007 | Dr. Robin J. Norris President and Chief Operating Officer | 250.0K | — | — | 313.2K | 27.0K | 3.5K | 593.7K | 52.76% | ↗ |
| 79 | 2007 | James A. Klein, Jr. Chief Financial Officer | 225.0K | — | — | 304.2K | 20.0K | 1.4K | 550.6K | 55.25% | ↗ |
| 80 | 2006 | Dr. William P. Peters Chief Executive Officer and Chairman | 486.9K | — | — | 62.3K | — | 2.4K | 551.6K | 11.29% | ↗ |
| 81 | 2006 | Dr. Robin J. Norris President and Chief Operating Officer | 245.4K | — | — | 72.2K | — | 2.3K | 320.0K | 22.58% | ↗ |
| 82 | 2006 | James A. Klein, Jr. Chief Financial Officer | 198.0K | — | — | 97.4K | — | 1.1K | 296.5K | 32.85% | ↗ |
| 83 | 2006 | D. Scott Murray, Senior Vice President, General Counsel and Secretary | 176.6K | — | — | 29.5K | — | 976.00 | 207.0K | 14.25% | ↗ |
| 84 | 2005 | Dr. William P. Peters Chief Executive Officer and Chairman | 454.2K | — | — | 588.9K | 60.0K | 2.3K | 1.11M | 53.27% | ↗ |
| 85 | 2005 | James A. Klein, Jr. Chief Financial Officer | 185.0K | — | — | 98.9K | 55.5K | 1.1K | 340.4K | 29.05% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2026-04-28 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jeffrey S. Hackman | Chief Executive Officer & Director | 632.2K | male |
| Robert C. Andrade | Chief Financial Officer | 552.6K | male |
| Pierre S. Sayad | Chief Medical Officer | 464.1K | — |
| Terry Evans | Chief Commercial Officer | — | male |
| Mark Gowland | Controller | — | male |
| Lei Fang | President of Pharstat Inc | — | male |
| Christiana Cioffi | Chief Strategy Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FENC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
